Global Diagnostic Biomarker Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 104

Report ID: 2150

Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various purposes such as disease diagnosis, prognosis, prediction and assessment of treatment response. The diagnostic biomarkers have early inferences for detection of Patent Ductus Arteriosus (PDA). Predictive markers provides personalize treatment regimens and prognostic markers predict patient survival and recurrence patterns. Biomarkers are used for clinical diagnostics for detecting multiple diseases, for instance, creatinine for diagnosing renal insufficiency, troponin level for diagnosing myocardial infarction and amylase for pancreatitis.
Revenue growth in the diagnostic biomarker is expected to gain traction in the near future as they are dependent on the prevalence of diseases such as cancer and other cardiac problems. Significant growth the sector of molecular biology and advancements in various laboratory techniques is expected to support the diagnostic biomarker market over the forecast period. The advancement in the technology and rise in adoption rate of the biomarkers in diagnosis has expanded the feasibility of the use of biomarkers in diagnosis of various disorders such as genetic, cardiac, cancer and other immunological diseases. Also, for clinical investigators the biomarkers can be a dynamic and powerful tool to analyze the spectrum of neurological disease.
In 2018, the global Diagnostic Biomarker market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Diagnostic Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diagnostic Biomarker development in United States, Europe and China.

The key players covered in this study
Biocrates Life Sciences
Augurex Life Sciences
Biomedical
Target Discovery
Banyan Biomarkers
Astute Medical
Axela
...

Market segment by Type, the product can be split into
S100
MART-1
Gp100
HMB45
AFP
BCR-ABL
Others

Market segment by Application, split into
Hospitals
Cancer Research Institutes
Diagnostic Labs

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Diagnostic Biomarker status, future forecast, growth opportunity, key market and key players.
To present the Diagnostic Biomarker development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Diagnostic Biomarker are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diagnostic Biomarker Market Size Growth Rate by Type (2014-2025)
1.4.2 S100
1.4.3 MART-1
1.4.4 Gp100
1.4.5 HMB45
1.4.6 AFP
1.4.7 BCR-ABL
1.4.8 Others
1.5 Market by Application
1.5.1 Global Diagnostic Biomarker Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Cancer Research Institutes
1.5.4 Diagnostic Labs
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Diagnostic Biomarker Market Size
2.2 Diagnostic Biomarker Growth Trends by Regions
2.2.1 Diagnostic Biomarker Market Size by Regions (2014-2025)
2.2.2 Diagnostic Biomarker Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Diagnostic Biomarker Market Size by Manufacturers
3.1.1 Global Diagnostic Biomarker Revenue by Manufacturers (2014-2019)
3.1.2 Global Diagnostic Biomarker Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Diagnostic Biomarker Market Concentration Ratio (CR5 and HHI)
3.2 Diagnostic Biomarker Key Players Head office and Area Served
3.3 Key Players Diagnostic Biomarker Product/Solution/Service
3.4 Date of Enter into Diagnostic Biomarker Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Diagnostic Biomarker Market Size by Type (2014-2019)
4.2 Global Diagnostic Biomarker Market Size by Application (2014-2019)

5 United States
5.1 United States Diagnostic Biomarker Market Size (2014-2019)
5.2 Diagnostic Biomarker Key Players in United States
5.3 United States Diagnostic Biomarker Market Size by Type
5.4 United States Diagnostic Biomarker Market Size by Application

6 Europe
6.1 Europe Diagnostic Biomarker Market Size (2014-2019)
6.2 Diagnostic Biomarker Key Players in Europe
6.3 Europe Diagnostic Biomarker Market Size by Type
6.4 Europe Diagnostic Biomarker Market Size by Application

7 China
7.1 China Diagnostic Biomarker Market Size (2014-2019)
7.2 Diagnostic Biomarker Key Players in China
7.3 China Diagnostic Biomarker Market Size by Type
7.4 China Diagnostic Biomarker Market Size by Application

8 Japan
8.1 Japan Diagnostic Biomarker Market Size (2014-2019)
8.2 Diagnostic Biomarker Key Players in Japan
8.3 Japan Diagnostic Biomarker Market Size by Type
8.4 Japan Diagnostic Biomarker Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Diagnostic Biomarker Market Size (2014-2019)
9.2 Diagnostic Biomarker Key Players in Southeast Asia
9.3 Southeast Asia Diagnostic Biomarker Market Size by Type
9.4 Southeast Asia Diagnostic Biomarker Market Size by Application

10 India
10.1 India Diagnostic Biomarker Market Size (2014-2019)
10.2 Diagnostic Biomarker Key Players in India
10.3 India Diagnostic Biomarker Market Size by Type
10.4 India Diagnostic Biomarker Market Size by Application

11 Central & South America
11.1 Central & South America Diagnostic Biomarker Market Size (2014-2019)
11.2 Diagnostic Biomarker Key Players in Central & South America
11.3 Central & South America Diagnostic Biomarker Market Size by Type
11.4 Central & South America Diagnostic Biomarker Market Size by Application

12 International Players Profiles
12.1 Biocrates Life Sciences
12.1.1 Biocrates Life Sciences Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diagnostic Biomarker Introduction
12.1.4 Biocrates Life Sciences Revenue in Diagnostic Biomarker Business (2014-2019)
12.1.5 Biocrates Life Sciences Recent Development
12.2 Augurex Life Sciences
12.2.1 Augurex Life Sciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diagnostic Biomarker Introduction
12.2.4 Augurex Life Sciences Revenue in Diagnostic Biomarker Business (2014-2019)
12.2.5 Augurex Life Sciences Recent Development
12.3 Biomedical
12.3.1 Biomedical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diagnostic Biomarker Introduction
12.3.4 Biomedical Revenue in Diagnostic Biomarker Business (2014-2019)
12.3.5 Biomedical Recent Development
12.4 Target Discovery
12.4.1 Target Discovery Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diagnostic Biomarker Introduction
12.4.4 Target Discovery Revenue in Diagnostic Biomarker Business (2014-2019)
12.4.5 Target Discovery Recent Development
12.5 Banyan Biomarkers
12.5.1 Banyan Biomarkers Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diagnostic Biomarker Introduction
12.5.4 Banyan Biomarkers Revenue in Diagnostic Biomarker Business (2014-2019)
12.5.5 Banyan Biomarkers Recent Development
12.6 Astute Medical
12.6.1 Astute Medical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Diagnostic Biomarker Introduction
12.6.4 Astute Medical Revenue in Diagnostic Biomarker Business (2014-2019)
12.6.5 Astute Medical Recent Development
12.7 Axela
12.7.1 Axela Company Details
12.7.2 Company Description and Business Overview
12.7.3 Diagnostic Biomarker Introduction
12.7.4 Axela Revenue in Diagnostic Biomarker Business (2014-2019)
12.7.5 Axela Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details